Skip to content

Join us at this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

An inter-species comparison of the triclopyr in vitro and in vivo toxicokinetic properties, for risk assessment purpose


16th April, 2021

Published by

Marco Corvaro, Michael Bartels, Colin Brown, Git Chung, Melissa Chan

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Please click the button below to download this resource.

Download Now

Get our latest updates straight to your inbox